 Joseph Sakai
Concepts (265)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conduct Disorder | 27 | 2023 | 193 | 8.720 |
Why?
| | Substance-Related Disorders | 29 | 2023 | 950 | 4.180 |
Why?
| | Adolescent Behavior | 8 | 2023 | 480 | 2.520 |
Why?
| | Emotions | 10 | 2023 | 477 | 2.140 |
Why?
| | Antisocial Personality Disorder | 12 | 2023 | 158 | 1.910 |
Why?
| | Empathy | 7 | 2023 | 140 | 1.640 |
Why?
| | Morals | 2 | 2023 | 65 | 1.450 |
Why?
| | Cannabis | 4 | 2023 | 381 | 1.430 |
Why?
| | Students, Medical | 4 | 2023 | 277 | 1.380 |
Why?
| | Mental Disorders | 8 | 2021 | 902 | 1.270 |
Why?
| | Risk-Taking | 8 | 2023 | 332 | 1.230 |
Why?
| | Helping Behavior | 2 | 2019 | 15 | 1.190 |
Why?
| | Adolescent | 45 | 2023 | 17889 | 1.140 |
Why?
| | Connectome | 2 | 2023 | 63 | 1.040 |
Why?
| | Brain | 10 | 2023 | 2370 | 1.020 |
Why?
| | Altruism | 2 | 2023 | 25 | 1.000 |
Why?
| | Opioid-Related Disorders | 3 | 2023 | 422 | 0.970 |
Why?
| | Medical Marijuana | 3 | 2017 | 97 | 0.960 |
Why?
| | Clinical Clerkship | 2 | 2023 | 75 | 0.950 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 3 | 2010 | 72 | 0.910 |
Why?
| | Psychiatry | 3 | 2023 | 155 | 0.890 |
Why?
| | Theory of Mind | 1 | 2023 | 9 | 0.870 |
Why?
| | Alcoholism | 10 | 2014 | 713 | 0.870 |
Why?
| | Psychology, Adolescent | 2 | 2016 | 62 | 0.860 |
Why?
| | Binge Drinking | 1 | 2023 | 32 | 0.850 |
Why?
| | Cerebral Cortex | 5 | 2017 | 386 | 0.800 |
Why?
| | Decision Making | 7 | 2017 | 791 | 0.790 |
Why?
| | Models, Psychological | 1 | 2023 | 299 | 0.770 |
Why?
| | Marijuana Abuse | 5 | 2017 | 209 | 0.770 |
Why?
| | Vaping | 1 | 2022 | 46 | 0.740 |
Why?
| | Tobacco Products | 1 | 2022 | 99 | 0.730 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2022 | 73 | 0.720 |
Why?
| | Magnetic Resonance Imaging | 15 | 2023 | 3069 | 0.690 |
Why?
| | Prescription Drug Misuse | 1 | 2020 | 38 | 0.670 |
Why?
| | Education, Medical | 1 | 2021 | 225 | 0.630 |
Why?
| | Humans | 69 | 2023 | 115587 | 0.620 |
Why?
| | Male | 50 | 2023 | 55949 | 0.610 |
Why?
| | Gray Matter | 2 | 2015 | 65 | 0.610 |
Why?
| | Case-Control Studies | 11 | 2023 | 3022 | 0.570 |
Why?
| | Female | 45 | 2023 | 59913 | 0.550 |
Why?
| | Gift Giving | 1 | 2016 | 9 | 0.540 |
Why?
| | Affective Symptoms | 1 | 2016 | 49 | 0.520 |
Why?
| | Suicide | 1 | 2021 | 501 | 0.510 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2014 | 1918 | 0.510 |
Why?
| | Cognition | 4 | 2023 | 980 | 0.500 |
Why?
| | Problem Behavior | 1 | 2015 | 86 | 0.460 |
Why?
| | Alcohol Drinking | 4 | 2023 | 648 | 0.430 |
Why?
| | Receptors, GABA-A | 2 | 2014 | 88 | 0.430 |
Why?
| | Receptors, Oxytocin | 1 | 2012 | 22 | 0.400 |
Why?
| | Marijuana Smoking | 2 | 2014 | 224 | 0.390 |
Why?
| | Sex Characteristics | 3 | 2023 | 641 | 0.380 |
Why?
| | Psychomotor Performance | 1 | 2013 | 278 | 0.380 |
Why?
| | Nerve Net | 1 | 2013 | 228 | 0.370 |
Why?
| | Ethanol | 2 | 2023 | 548 | 0.350 |
Why?
| | Social Behavior | 1 | 2012 | 269 | 0.340 |
Why?
| | Receptors, Dopamine D2 | 2 | 2007 | 85 | 0.330 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 5 | 2009 | 230 | 0.320 |
Why?
| | Games, Experimental | 2 | 2019 | 9 | 0.300 |
Why?
| | Legislation, Drug | 2 | 2022 | 73 | 0.300 |
Why?
| | Neuroimaging | 3 | 2019 | 247 | 0.280 |
Why?
| | Reproducibility of Results | 5 | 2023 | 2800 | 0.270 |
Why?
| | Alcohol-Related Disorders | 1 | 2007 | 110 | 0.270 |
Why?
| | Aggression | 2 | 2009 | 185 | 0.260 |
Why?
| | Young Adult | 8 | 2023 | 10470 | 0.260 |
Why?
| | Reward | 3 | 2019 | 208 | 0.260 |
Why?
| | Colorado | 9 | 2020 | 4113 | 0.260 |
Why?
| | Adult | 21 | 2023 | 30718 | 0.250 |
Why?
| | Blood Chemical Analysis | 1 | 2006 | 90 | 0.250 |
Why?
| | Substance Abuse Detection | 1 | 2006 | 62 | 0.250 |
Why?
| | Monitoring, Ambulatory | 1 | 2006 | 82 | 0.250 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 691 | 0.240 |
Why?
| | Brain Mapping | 5 | 2019 | 521 | 0.240 |
Why?
| | United States | 10 | 2022 | 12295 | 0.230 |
Why?
| | Polymorphism, Genetic | 1 | 2006 | 621 | 0.220 |
Why?
| | Guilt | 1 | 2023 | 11 | 0.220 |
Why?
| | Charities | 1 | 2023 | 9 | 0.220 |
Why?
| | Marriage | 1 | 2004 | 106 | 0.220 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 267 | 0.220 |
Why?
| | Siblings | 3 | 2009 | 223 | 0.210 |
Why?
| | Impulsive Behavior | 2 | 2015 | 109 | 0.210 |
Why?
| | Happiness | 1 | 2022 | 22 | 0.210 |
Why?
| | Promoter Regions, Genetic | 1 | 2006 | 1122 | 0.210 |
Why?
| | Child | 12 | 2022 | 18488 | 0.200 |
Why?
| | Odds Ratio | 2 | 2020 | 962 | 0.200 |
Why?
| | Faculty | 1 | 2023 | 131 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 2 | 2008 | 2125 | 0.200 |
Why?
| | Unsafe Sex | 2 | 2020 | 58 | 0.200 |
Why?
| | Electronics | 1 | 2022 | 68 | 0.190 |
Why?
| | Affect | 1 | 2023 | 244 | 0.190 |
Why?
| | Family | 4 | 2009 | 594 | 0.190 |
Why?
| | Educational Measurement | 1 | 2023 | 262 | 0.180 |
Why?
| | Phenotype | 4 | 2010 | 2829 | 0.180 |
Why?
| | Social Stigma | 1 | 2021 | 88 | 0.180 |
Why?
| | Enuresis | 1 | 2000 | 3 | 0.180 |
Why?
| | Fear | 1 | 2022 | 297 | 0.170 |
Why?
| | Patient Acceptance of Health Care | 1 | 2005 | 682 | 0.170 |
Why?
| | Substance Abuse, Intravenous | 2 | 2013 | 99 | 0.170 |
Why?
| | Education, Distance | 1 | 2019 | 39 | 0.170 |
Why?
| | Psychomotor Agitation | 1 | 2019 | 66 | 0.170 |
Why?
| | Tobacco Use | 1 | 2020 | 59 | 0.170 |
Why?
| | Prevalence | 6 | 2014 | 2264 | 0.160 |
Why?
| | Craving | 1 | 2019 | 31 | 0.160 |
Why?
| | Data Collection | 2 | 2014 | 636 | 0.160 |
Why?
| | Logistic Models | 3 | 2020 | 1856 | 0.160 |
Why?
| | Physician Incentive Plans | 1 | 2018 | 6 | 0.160 |
Why?
| | Multimodal Imaging | 1 | 2019 | 98 | 0.160 |
Why?
| | Mental Health | 2 | 2021 | 571 | 0.160 |
Why?
| | Sex Factors | 4 | 2017 | 1736 | 0.160 |
Why?
| | Adolescent Development | 1 | 2019 | 83 | 0.160 |
Why?
| | Clinical Competence | 2 | 2023 | 912 | 0.160 |
Why?
| | Professional-Patient Relations | 1 | 2019 | 143 | 0.160 |
Why?
| | Tuberculin Test | 1 | 1998 | 32 | 0.150 |
Why?
| | Linkage Disequilibrium | 3 | 2008 | 247 | 0.150 |
Why?
| | Automobile Driving | 1 | 2020 | 129 | 0.150 |
Why?
| | Surveys and Questionnaires | 6 | 2018 | 4665 | 0.150 |
Why?
| | Violence | 1 | 2019 | 202 | 0.150 |
Why?
| | Cross-Sectional Studies | 5 | 2020 | 4435 | 0.140 |
Why?
| | Comorbidity | 7 | 2015 | 1473 | 0.140 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1998 | 112 | 0.140 |
Why?
| | Physicians, Family | 1 | 2018 | 201 | 0.140 |
Why?
| | Suicidal Ideation | 1 | 2021 | 399 | 0.140 |
Why?
| | Genotype | 4 | 2014 | 1786 | 0.140 |
Why?
| | Marijuana Use | 1 | 2020 | 164 | 0.140 |
Why?
| | Writing | 1 | 2018 | 85 | 0.140 |
Why?
| | Suicide, Attempted | 1 | 2020 | 316 | 0.140 |
Why?
| | Organ Size | 2 | 2015 | 434 | 0.140 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2000 | 194 | 0.140 |
Why?
| | Psychotic Disorders | 1 | 1998 | 123 | 0.140 |
Why?
| | Drug Prescriptions | 1 | 2018 | 241 | 0.140 |
Why?
| | California | 1 | 2017 | 367 | 0.140 |
Why?
| | Parents | 1 | 2004 | 1205 | 0.140 |
Why?
| | Moral Obligations | 1 | 2016 | 10 | 0.130 |
Why?
| | Self Report | 2 | 2020 | 698 | 0.130 |
Why?
| | Photic Stimulation | 1 | 2017 | 203 | 0.130 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 499 | 0.130 |
Why?
| | Mental Competency | 1 | 2015 | 25 | 0.130 |
Why?
| | Genetics, Population | 2 | 2007 | 192 | 0.130 |
Why?
| | Research Subjects | 1 | 2015 | 40 | 0.130 |
Why?
| | Frontal Lobe | 2 | 2015 | 139 | 0.130 |
Why?
| | Learning | 1 | 2019 | 358 | 0.130 |
Why?
| | Biological Specimen Banks | 1 | 2015 | 95 | 0.120 |
Why?
| | Gambling | 1 | 2015 | 31 | 0.120 |
Why?
| | Informed Consent | 1 | 2015 | 161 | 0.120 |
Why?
| | Patient Satisfaction | 1 | 2018 | 585 | 0.120 |
Why?
| | Risk Factors | 6 | 2013 | 8697 | 0.120 |
Why?
| | Accidents, Traffic | 1 | 2014 | 170 | 0.110 |
Why?
| | Polymorphism, Restriction Fragment Length | 2 | 2007 | 65 | 0.110 |
Why?
| | Juvenile Delinquency | 3 | 2008 | 103 | 0.100 |
Why?
| | Limbic System | 1 | 2012 | 43 | 0.100 |
Why?
| | Longitudinal Studies | 5 | 2014 | 2416 | 0.100 |
Why?
| | Attitude | 1 | 2014 | 229 | 0.100 |
Why?
| | Signal Processing, Computer-Assisted | 2 | 2019 | 137 | 0.100 |
Why?
| | Curriculum | 1 | 2018 | 852 | 0.100 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 783 | 0.100 |
Why?
| | Genomics | 1 | 2015 | 645 | 0.090 |
Why?
| | DNA Primers | 2 | 2010 | 514 | 0.090 |
Why?
| | Age Factors | 2 | 2014 | 2907 | 0.090 |
Why?
| | Hawaii | 1 | 2010 | 38 | 0.090 |
Why?
| | Middle Aged | 8 | 2020 | 26999 | 0.090 |
Why?
| | Urban Population | 1 | 2012 | 405 | 0.090 |
Why?
| | Nuclear Family | 1 | 2009 | 49 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2013 | 440 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 485 | 0.080 |
Why?
| | Primary Health Care | 1 | 2018 | 1518 | 0.080 |
Why?
| | Base Sequence | 2 | 2010 | 2114 | 0.080 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2008 | 40 | 0.080 |
Why?
| | Diseases in Twins | 1 | 2009 | 175 | 0.070 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2007 | 17 | 0.070 |
Why?
| | Acculturation | 1 | 2007 | 52 | 0.070 |
Why?
| | Mouth Mucosa | 1 | 2007 | 79 | 0.070 |
Why?
| | Taq Polymerase | 1 | 2006 | 10 | 0.070 |
Why?
| | Inheritance Patterns | 1 | 2006 | 45 | 0.070 |
Why?
| | Twins, Dizygotic | 1 | 2007 | 182 | 0.070 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 136 | 0.070 |
Why?
| | Twins, Monozygotic | 1 | 2007 | 210 | 0.070 |
Why?
| | Hospitals, Veterans | 1 | 2007 | 245 | 0.070 |
Why?
| | Water Loss, Insensible | 1 | 2006 | 2 | 0.070 |
Why?
| | Residential Treatment | 1 | 2006 | 31 | 0.070 |
Why?
| | Attitude of Health Personnel | 2 | 2018 | 990 | 0.070 |
Why?
| | Breath Tests | 1 | 2006 | 83 | 0.060 |
Why?
| | Reference Values | 1 | 2006 | 744 | 0.060 |
Why?
| | Alcoholic Intoxication | 1 | 2006 | 63 | 0.060 |
Why?
| | Demography | 1 | 2006 | 261 | 0.060 |
Why?
| | Regression Analysis | 1 | 2007 | 959 | 0.060 |
Why?
| | Alleles | 1 | 2007 | 794 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2006 | 4440 | 0.060 |
Why?
| | Tobacco Use Disorder | 1 | 2006 | 235 | 0.060 |
Why?
| | Acute Coronary Syndrome | 1 | 2007 | 254 | 0.060 |
Why?
| | Hospitals, University | 1 | 2004 | 172 | 0.060 |
Why?
| | Administration, Inhalation | 1 | 2006 | 644 | 0.060 |
Why?
| | Equipment Design | 1 | 2006 | 517 | 0.060 |
Why?
| | Smoking | 2 | 2012 | 1457 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 724 | 0.060 |
Why?
| | Statistics, Nonparametric | 1 | 2004 | 390 | 0.060 |
Why?
| | Adaptation, Psychological | 1 | 2007 | 551 | 0.050 |
Why?
| | DNA | 2 | 2007 | 1356 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 1870 | 0.050 |
Why?
| | Transcription, Genetic | 1 | 2007 | 1310 | 0.050 |
Why?
| | Depressive Disorder, Major | 1 | 2004 | 304 | 0.050 |
Why?
| | Psychometrics | 3 | 2009 | 615 | 0.050 |
Why?
| | Interview, Psychological | 2 | 2012 | 91 | 0.040 |
Why?
| | Substance Abuse Treatment Centers | 2 | 2012 | 43 | 0.040 |
Why?
| | Adenoidectomy | 1 | 2000 | 60 | 0.040 |
Why?
| | Child Abuse | 1 | 2004 | 455 | 0.040 |
Why?
| | HIV Infections | 1 | 2013 | 2473 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 85 | 0.040 |
Why?
| | Tonsillectomy | 1 | 2000 | 72 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 54 | 0.040 |
Why?
| | Attention | 1 | 2021 | 394 | 0.040 |
Why?
| | Health Surveys | 2 | 2012 | 446 | 0.040 |
Why?
| | Epidemics | 1 | 2018 | 70 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2019 | 284 | 0.040 |
Why?
| | Internal-External Control | 1 | 2017 | 67 | 0.040 |
Why?
| | Cues | 1 | 2019 | 297 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2004 | 2578 | 0.030 |
Why?
| | Receptors, Serotonin | 1 | 1996 | 32 | 0.030 |
Why?
| | Game Theory | 1 | 2015 | 9 | 0.030 |
Why?
| | Education, Medical, Undergraduate | 1 | 2018 | 174 | 0.030 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2015 | 22 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6165 | 0.030 |
Why?
| | Motivation | 1 | 2018 | 498 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2020 | 6417 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2008 | 1718 | 0.030 |
Why?
| | Heroin Dependence | 1 | 2012 | 22 | 0.030 |
Why?
| | Condoms | 1 | 2013 | 113 | 0.030 |
Why?
| | Radiography | 1 | 2015 | 826 | 0.030 |
Why?
| | Amphetamine-Related Disorders | 1 | 2012 | 29 | 0.030 |
Why?
| | Gyrus Cinguli | 1 | 2012 | 69 | 0.030 |
Why?
| | Family Conflict | 1 | 2012 | 37 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2006 | 9159 | 0.030 |
Why?
| | Sexual Partners | 1 | 2013 | 164 | 0.020 |
Why?
| | Schizophrenia | 1 | 1996 | 418 | 0.020 |
Why?
| | Family Relations | 1 | 2012 | 87 | 0.020 |
Why?
| | Cocaine-Related Disorders | 1 | 2012 | 107 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2014 | 1000 | 0.020 |
Why?
| | Neural Pathways | 1 | 2012 | 260 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2007 | 12608 | 0.020 |
Why?
| | Patient Admission | 1 | 2012 | 175 | 0.020 |
Why?
| | Social Environment | 1 | 2012 | 286 | 0.020 |
Why?
| | Aged | 3 | 2020 | 19251 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1180 | 0.020 |
Why?
| | Cerebellum | 1 | 2011 | 200 | 0.020 |
Why?
| | Prospective Studies | 2 | 2013 | 6264 | 0.020 |
Why?
| | Personality Inventory | 1 | 2009 | 135 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2012 | 919 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1440 | 0.020 |
Why?
| | Hippocampus | 1 | 2012 | 709 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 2987 | 0.020 |
Why?
| | Sex Distribution | 1 | 2007 | 337 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 324 | 0.020 |
Why?
| | Age of Onset | 1 | 2006 | 450 | 0.020 |
Why?
| | Health Services Research | 1 | 2007 | 377 | 0.020 |
Why?
| | Models, Genetic | 1 | 2007 | 570 | 0.010 |
Why?
| | Nicotine | 1 | 2006 | 266 | 0.010 |
Why?
| | Survival Analysis | 1 | 2007 | 1219 | 0.010 |
Why?
| | United States Department of Veterans Affairs | 1 | 2007 | 557 | 0.010 |
Why?
| | Perception | 1 | 2006 | 315 | 0.010 |
Why?
| | Schools | 1 | 2006 | 400 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2007 | 779 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1435 | 0.010 |
Why?
| | Incidence | 1 | 2008 | 2335 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1490 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2007 | 931 | 0.010 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 1996 | 19 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1996 | 2790 | 0.010 |
Why?
|
|
Sakai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|